Podchaser Logo
Home
145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

Released Wednesday, 23rd May 2018
Good episode? Give it some love!
145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

Wednesday, 23rd May 2018
Good episode? Give it some love!
Rate Episode

Wednesday, May 23, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

0:45 FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes https://www.prnewswire.com/news-releases/fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes-300652146.html

2:10 Providence Medical Technology announces FDA 510(k) clearance for DTRAX® Spinal System https://www.prnewswire.com/news-releases/providence-medical-technology-announces-fda-510k-clearance-for-dtrax-spinal-system-300652309.html 

3:38 FDA approves Prolia® (denosumab) for glucocorticoid-induced osteoporosis https://www.prnewswire.com/news-releases/fda-approves-prolia-denosumab-for-glucocorticoid-induced-osteoporosis-300652126.html 

5:20 FDA approves Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease https://www.prnewswire.com/news-releases/fda-approves-new-drug-for-patients-with-chronic-liver-disease-who-have-low-blood-platelets-and-are-undergoing-a-medical-procedure-300651897.html https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608320.htm

7:20 Cerenovus receives FDA clearance for next generation stent retriever device used to treat ischemic stroke https://www.prnewswire.com/news-releases/cerenovus-receives-fda-clearance-for-next-generation-stent-retriever-device-used-to-treat-ischemic-stroke-300651419.html 

9:44 FDA approves Restylane® Lyft dermal filler for hands https://www.prnewswire.com/news-releases/nestle-skin-health-announces-the-fda-approval-of-restylane-lyft-for-hands-the-first-and-only-hyaluronic-acid-ha-dermal-filler-for-use-in-the-back-of-hands-300651736.html 

11:04 New FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608499.htm 

Brought to you by Nascent Medical. For assistance with medical writing, please email [email protected]

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features